Drug Discovery & Development Insights by OmicsX
No Result
View All Result
  • Login
  • Register
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
PRICING
SUBSCRIBE
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
No Result
View All Result
Drug Discovery & Development Insights by OmicsX
No Result
View All Result
Home Big Pharma

Boehringer Ingelheim GmbH –
Oncology Deals and Alliances Insights

Oncology Acquisitions, Deals & Collaboration Strategies

Team OmicsX by Team OmicsX
June 15, 2021
in Big Pharma, Channels, Deals & Collaborations (BP), Oncology
493
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

Boehringer Ingelheim is a research-driven company operating worldwide under two divisions: Human Pharmaceuticals and Animal Healthcare. In oncology,  Boehringer Ingelheim is mainly focused on three areas: angiogenesis inhibition, EGFR inhibition and cell cycle kinase inhibition.

Support authors and subscribe to content

This is premium stuff. Subscribe to read the entire article.

Login if you have purchased

Subscribe

Gain access to all our Premium contents.
More than 100+ articles.
Subscribe Now

Buy Single Article

Unlock this article and gain permanent access to read it.
Unlock Now
Previous Post

Gilead Sciences, Inc. –
Oncology Deals and Alliances Insights

Next Post

Gilead Sciences, Inc. –
Oncology Drug Pipeline Insights – June 2021

Next Post
Gilead Sciences, Inc. – Oncology Drug Pipeline Insights – June 2021

Gilead Sciences, Inc. -
Oncology Drug Pipeline Insights - June 2021

Drug Discovery & Development Insights by OmicsX

Mapping Bio-Innovations

updated.. easy.. precise... complete...

Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.

LEARN MORE »

  • Trending
  • Comments
  • Latest
Approved Monoclonal Antibodies for Cancer Treatment

Approved Monoclonal Antibodies for Cancer Treatment

July 1, 2021
Worldwide 73 Approved Oncology Targeting Small Molecule Kinase Inhibitors

Worldwide 73 Approved Oncology Targeting Small Molecule Kinase Inhibitors

June 30, 2021

Small Molecule Kinase Inhibitors – Preclinical Drug Developers Profiles

July 1, 2021

Global Cancer Targeting Small Molecule Kinase Inhibitors in Preclinical Development – 2021

July 3, 2021
Approved Monoclonal Antibodies for Cancer Treatment

Approved Monoclonal Antibodies for Cancer Treatment

1
Cancer Targeting Clinical Stage Monoclonal Antibodies in Active Development – 2021

Cancer Targeting Clinical Stage Monoclonal Antibodies in Active Development – 2021

1
Cancer Targeting Pre-Clinical Stage Monoclonal Antibodies in Active Development – 2021

Cancer Targeting Pre-Clinical Stage Monoclonal Antibodies in Active Development – 2021

1
Cancer Targeting Pre-Clinical Stage Monoclonal Antibodies in Active Development – 2021

Cancer Targeting Clinical Stage Bispecific Antibodies in Active Development – 2021

1
Approved Small Molecule Kinase (Non-Oncology) Inhibitors

test onco deals and alliance

May 27, 2022

Targeted Cancer Therapies in Development – Antibodies

July 1, 2021

Cancer Targeting Small Molecule Epigenetic Drugs in Development – An Overview

May 27, 2022

Global Cancer Targeting Small Molecule Epigenetic Inhibitors – 2021

June 30, 2021

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

No Result
View All Result
  • Home
  • Subscription
  • Category
    • Opinion
    • Tech
  • Landing Page
  • Buy JNews
  • Support Forum
  • Pre-sale Question
  • Contact Us

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?